Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Saturday, July 11, 2026
🇺🇸 FDA

naloxone News

🇺🇸 FDA ← All news

FDA naloxone coverage for business development, investment, and market access teams

High impact NewsJun 16, 2026

FDA approves OTC Rextovy, broadening naloxone access for opioid overdose

FDA · opioid overdose · 6 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves First OTC Naloxone Nasal Spray for Opioid Overdose

FDA · Opioid Overdose Treatment · 5 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.